Autologous and Allogenic Utilization of Stromal Vascular Fraction and Decellularized Extracellular Matrices in Orthopedic Surgery: A Scoping Review

Document Type : SCOPING REVIEW


Department of Orthopaedic Surgery, La Paz University Hospital, Madrid, Spain


Background: This narrative review of the literature aims to analyze the utilization of stromal vascular fraction (SVF)
and decellularized extracellular matrices (dECMs) in various pathologies related to orthopedic surgery.
Methods: A literature search was carried out in PubMed on February 15, 2022, using “Stroma Vascular Fraction and
Orthopedic Surgery” and “Decellularized Extracellular Matrices and Orthopedic Surgery” as keywords. A total of 278
articles were found, of which 28 papers were selected because they seemed to be the most appropriate concerning
the title of the article.
Results: The reported results have shown that intra-articular injection of SVF seems to be a safe and efficacious
method for managing knee osteoarthritis (OA). Platelet-rich plasma (PRP) and SVF are safe and effective management
for intractable Achilles tendinopathy in humans, although subjects treated with SVF recover earlier. There are promising
results in utilizing adipose-derived mesenchymal stromal cells in chronic lateral epicondylitis of the elbow in athletes.
Ready-to-use ECM/SVF gel seems to be a good therapeutic option promoting the regeneration of the articular cartilage
in subjects with injuries of the cartilage. The SVF can safely be used to treat diabetic subjects suffering from chronic
foot ulcers.
Conclusion: There are scarce high-quality data for utilizing cell-based approach in soft tissue injuries of the knee in
athletes. Experimental studies indicate that SVF could be a new option to osseous regeneration. Other experimental
studies support the utilization of dECMs as a scaffold for the regeneration of large osseous defects, cell-derived dECMs
scaffolds to repair articular cartilage injuries, and utilization of xenogeneic acellular muscles to manage volumetric
muscle loss where there is a lack of donor site.
Intra-articular injections of SVF seems to be a safe and efficacious method for managing OA of the knee joint. Plateletrich
plasma (PRP) and SVF are safe and efficacious methods for the management of intractable Achilles tendinopathy
in humans, although subjects treated with SVF recover earlier.
Level of evidence: III


1. Van Schaik KD, Kenneth SL. Orthobiologics: diagnosis
and treatment of common tendinopathies. Semin
Musculoskelet Radiol 2021;25(6):735-44.
2. Gentile P, Sterodimas A, Pizzicannella J, Dionisi L,
De Fazio D, Calabrese C, et al. Systematic Review:
allogenic use of stromal vascular fraction (SVF)
and decellularized extracellular matrices (ECM) as
advanced therapy medicinal products (ATMP) in
tissue regeneration. Int J Mol Sci. 2020;21(14):4982.
3. Blaudez F, Ivanovski S, Hamlet S, Vaquette C. An
overview of decellularisation techniques of native
tissues and tissue engineered products for bone,
ligament and tendon regeneration. Methods.
4. Mehranfar S, Abdi Rad I, Mostafav E, Akbarzadeh A.
The use of stromal vascular fraction (SVF), plateletrich
plasma (PRP) and stem cells in the treatment of
osteoarthritis: an overview of clinical trials. Artif Cells
Nanomed Biotechnol. 2019;47(1):882-90.
5. Pak J, Lee JH, Pak N, Pak Y, Park KS, Jeon JH, et al.
Cartilage regeneration in humans with adipose
tissue-derived stem cells and adipose stromal
vascular fraction cells: updated status. Int J Mol Sci.
6. Fotouhi A, Maleki A, Dolati S, Aghebati-Maleki A,
Aghebati-Maleki L. Platelet rich plasma, stromal
vascular fraction and autologous conditioned
serum in treatment of knee osteoarthritis. Biomed
Pharmacother. 2018;104:652-60.
7. Di Matteo B, Vandenbulcke F, Vitale ND, Iacono F,
Ashmore K, Marcacci M, et al. Minimally manipulated
mesenchymal stem cells for the treatment of knee
osteoarthritis: a systematic review of clinical
evidence. Stem Cells Int. 2019;2019:1735242.
8. Yokota N, Hattori M, Ohtsuru T, Otsuji M, Lyman S,
Shimomura K, et al. Comparative clinical outcomes
after intra-articular injection with adipose-derived
cultured stem cells or noncultured stromal vascular
fraction for the treatment of knee osteoarthritis. Am J
Sports Med. 2019;47(11):2577-83.
9. Garza JR, Campbell RE, Tjoumakaris FP, Freedman KB,
Miller LS, Santa Maria D, et al. Clinical efficacy of intraarticular
mesenchymal stromal cells for the treatment
of knee osteoarthritis: a double-blinded prospective
randomized controlled clinical trial. Am J Sports Med.
10. Tsubosaka M, Matsumoto T, Sobajima S, Matsushita
T, Iwaguro H, Kuroda R. The influence of adiposederived
stromal vascular fraction cells on the
treatment of knee osteoarthritis. BMC Musculoskelet
Disord. 2020;21(1):207.
11. Shanmugasundaram S, Vaish A, Chavada V, Murrell
WD, Vaishya R. Assessment of safety and efficacy of
intra-articular injection of stromal vascular fraction
for the treatment of knee osteoarthritis-a systematic
review. Int Orthop. 2021;45(3):615-25.
12. Filardo G, Tschon M, Perdisa F, Brogini S, Cavallo
C, Desando G, et al. Micro-fragmentation is a
valid alternative to cell expansion and enzymatic
digestion of adipose tissue for the treatment of knee osteoarthritis: a comparative preclinical study. Knee
Surg Sports Traumatol Arthrosc. 2021 Jan 19. doi:
10.1007/s00167-020-06373-y. Online ahead of print.
PMID: 33464397.
13. Usuelli FG, Grassi M, Maccario C, Vigano M, Lanfranchi
L, Alfieri Montrasio U, et al. Intratendinous adiposederived
stromal vascular fraction (SVF) injection
provides a safe, efficacious treatment for Achilles
tendinopathy: results of a randomized controlled
clinical trial at a 6-month follow-up. Knee Surg Sports
Traumatol Arthrosc. 2018;26(7):2000-10.
14. Khoury M, Tabben M, Rolón AU, Levi L, Chamari K,
PD’Hooghe P. Promising improvement of chronic
lateral elbow tendinopathy by using adipose derived
mesenchymal stromal cells: a pilot study. J Exp Orthop
15. Li Q, Zhao F, Li Z, Duan X, Cheng J, Zhang J, et al.
Autologous fractionated adipose tissue as a natural
biomaterial and novel one-step stem cell therapy for
repairing articular cartilage defects. Front Cell Dev
Biol. 2020;8:694.
16. Carstens MH, Quintana FJ, Calderwood ST, Sevilla JP,
Rí􀆴os AB, Rivera CM, et al. Treatment of chronic diabetic
foot ulcers with adipose-derived stromal vascular
fraction cell injections: Safety and evidence of efficacy
at 1 year. Stem Cells Transl Med. 2021;10(8):1138-47.
17. Kader N, Asopa V, Baryeh K, Sochart D, Maffulli N,
Kader D. Cell-based therapy in soft tissue sports
injuries of the knee: a systematic review. Expert Opin
Biol Ther. 2021;21(8):1035-47.
18. Zhang Y, Grosfeld EC, Camargo WA, Tang H, Magri AMP,
van den Beucken JJJP. Efficacy of intraoperatively
prepared cell-based constructs for bone regeneration.
Stem Cell Res Ther. 2018;9(1):283.
19. Bari E, Roato I, Perale G, Rossi F, Genova T, Mussano F, et
al. Biohybrid bovine bone matrix for controlled release
of mesenchymal stem/stromal cell lyosecretome:
a device for bone regeneration. Int J Mol Sci.
20. Cunniffe GM, Dí􀆴az-Payno PJ, Ramey JS, Mahon
OR, Dunne A, Thompson EM, et al. Growth plate
extracellular matrix-derived scaffolds for large bone
defect healing. Eur Cell Mater. 2017;33:130-42.
21. Ghassemi T, Shahroodi A, Ebrahimzadeh MH,
Mousavian A, Movaffagh J, Moradi A. Current concepts
in scaffolding for bone tissue engineering. Arch Bone
Jt Surg 2018;6(2):90-9.
22. Freeman FE, Browe DC, Nulty J, Von Euw S, Grayson
WL, Kelly DJ. Biofabrication of multiscale bone
extracellular matrix scaffolds for bone tissue
engineering. Eur Cell Mater. 2019;38:168-87.
23. Moradi A, Ataollahi F, Sayar K, Pramanik S, Chong PP,
Khalil AA, et al. Chondrogenic potential of physically
treated bovine cartilage matrix derived porous
scaffolds on human dermal fibroblast cells. J Biomed
Mater Res A 2016;104(1):245-56.
24. Ghassemi T, Saghatolslami N, Matin MM, Gheshlaghi
R, Moradi A. CNT-decellularized cartilage hybrids
for tissue engineering applications. Biomed Mater
25. Zhu W, Cao L, Song C, Pang Z, Jiang H, Guo C. Cellderived
decellularized extracellular matrix scaffolds
for articular cartilage repair. Int J Artif Organs.
26. Zhang X, Liu Y, Luo C, Zhai C, Li Z, Zhang Y, et al.
Crosslinker-free silk/decellularized extracellular
matrix porous bioink for 3D bioprinting-based
cartilage tissue engineering. Mater Sci Eng C Mater
Biol Appl. 2021;118:111388.
27. Kim HS, Mandakhbayar N, Kim HW, Leong KW,
Yoo HS. Protein-reactive nanofibrils decorated
with cartilage derived decellularized extracellular
matrix for osteochondral defects. Biomaterials.
28. Urciuolo A, Urbani L, Perin S, Maghsoudlou P, Scottoni
F, Gjinovci A, et al. Decellularised skeletal muscles
allow functional muscle regeneration by promoting
host cell migration. Sci Rep. 2018;8(1):8398.
Volume 10, Issue 10
October 2022
Pages 827-832
  • Receive Date: 11 August 2021
  • Revise Date: 01 March 2022
  • Accept Date: 05 March 2022
  • First Publish Date: 20 September 2022